Should I buy Amgen Inc. (AMGN)?

What Strong Buy means for AMGN today

A Strong Buy rating is the output of the composite fair-value band ($367–$644) compared with the live price ($329), a 9/10 moat score, and a 88/100 confidence reading on the data quality and model convergence behind the fair-value range. We do not issue Buy / Strong Buy unless valuation is in the strong half of our six-factor decision overlay AND the risk profile is non-elevated; the rating is gated, not free-form.

AMGN is rated Strong Buy at $329.09 versus the reconciled fair value midpoint of $505.34, implying +53.56% upside/downside. Confidence is separately disclosed at 88/100. The full report explains every input: discount rate, terminal growth, deceleration curve, scenario probabilities, and where the rating could change next.

Bull, base and bear over our base horizon

Bull case (probability 20%): target $644.16, return +95.7%. Base case (probability 60%): target $505.34, return +53.6%. Bear case (probability 20%): target $366.98, return +11.5%.

Probability weights are not symmetric. Amgen Inc. is a mature compounder stock, so the deceleration curve, terminal P/E, and confidence in the bull tail are calibrated to that archetype. The probability-weighted expected value in the full report folds these three scenarios into a single asymmetric expected return — a more honest "should I buy?" signal than any single point estimate.

Risks to the thesis

The top kill-scenarios our latest report flags for Amgen Inc. are: MariTide Clinical Failure; Aggressive IRA Pricing; M&A Deleveraging Trap. The single biggest risk is Growth: High-optionality pipeline in obesity offers massive upside not currently priced in.

The biggest opportunity is Contrarian: The market's -0.48% growth assumption is overly pessimistic and ignores structural cash power. Position management in the full report converts the rating into concrete checkpoints — quarterly reassessment triggers and the metric thresholds that should change the size of the position rather than the position itself.

Bottom line

Our Strong Buy rating with 88/100 confidence is research for educational purposes — not personalised investment advice and not a price call. Use the fair-value range and the bull/base/bear distribution to size a view; use the kill-scenarios and the earnings decision tree to define what would invalidate it.

For the full evidence — 14 sections, sensitivity grid, scorecard, and the data-provenance appendix — see the canonical report at /stocks/amgn/analysis.

Frequently asked questions